IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice - Wikidata - wikimedia - TriplyDB

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

http://www.wikidata.org/entity/Q35023076

about

Type-2 innate lymphoid cells control the development of atherosclerosis in mice Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis Group 2 innate lymphoid cells in disease.Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation.The Innate Immune Response in Myocardial Infarction, Repair, and Regeneration.The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond

P2860

Q33786641-18A78515-998B-44C9-9791-A097C5E0F45E Q35640438-7DA4B66A-18C4-47CE-B9D7-32B130327352 Q36475881-4A31406E-7E93-4840-8C42-0F5CB880D464 Q38573631-D351F098-7C40-40D5-9159-AA34E14D12F6 Q38846881-0B1C9FE4-9AC4-49E1-910B-778840FA59E1 Q40665206-01F65BE5-10A6-4349-A7A9-0AE785409D94 Q51835824-0ACA368E-814E-4010-B648-E86237818549 Q58803307-FC2415DE-4006-424F-AEA6-E7A593772C08

P2860

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

http://www.wikidata.org/entity/Q35023076

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

@ast

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

@en

type

label

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

@ast

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

@en

prefLabel

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

@ast

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

@en

P1433

Q35023076-38181DA2-90D5-47CA-8F52-1706B6D6B4EE

P1476

Q35023076-2663FB56-CEF2-4603-9C8D-9832374EBBAB

P2093

Q35023076-2B4C9A05-2AB0-4DEC-A42A-C9EEE969E2D9

Q35023076-3305A1BC-13FF-4F14-A68D-4E48EE0B6B81

Q35023076-3703A6C9-DEE3-4E9B-B2E7-E450B4957725

Q35023076-7036C8D2-DA08-49C3-AD35-13E84C3F5B40

Q35023076-75D51333-5F6C-4D71-8CC5-E3B2D77D8A43

Q35023076-B18C0E08-9966-48D9-BB65-D7BDCA049FB5

Q35023076-CFE8387F-97EC-4169-93C2-7D92075D8513

Q35023076-D96D53A8-96D5-4E12-8A83-420E6FDA8201

Q35023076-EFAACD72-3FC7-4160-8AC9-70942379B003

P2860

Q35023076-07E69430-D2A7-4AA2-BC5E-DB81459409B3

Q35023076-0B141CC4-D57A-472F-BF7F-B72157850DFF

Q35023076-0BE51EDD-3512-446A-8722-2D1871A250A2

Q35023076-0FED81F9-B703-4D3E-A277-B12B64220FA4

Q35023076-1D53B0B7-ECDF-43FA-B5F1-B45396D106C1

Q35023076-1F536019-3EC6-4AE8-B3E9-F588D6E8D09D

Q35023076-26848419-F074-4381-B913-E22BCE0CA80D

Q35023076-2FC1C52C-7B33-4609-9992-A476F7F61FA5

Q35023076-3091C636-733B-4C09-BAD8-7A52B7436AA3

Q35023076-35BCEAA2-0D38-465B-B20A-4A9B6B4C84B8

P304

Q35023076-AB20C2BB-6A14-419B-8E0A-01D4F1730A00

P31

Q35023076-34E1B772-2903-4FBA-AFDC-CC394A57E235

P356

Q35023076-69848FD0-658E-42FB-AB8F-B8B148A511AA

P407

Q35023076-CB3589C5-D46F-4296-B234-24D29550E34B

P433

Q35023076-1860EC38-C730-4319-A3A3-A554E1E56384

P478

Q35023076-ABD7FBEB-225B-466A-AC90-DFA838ED02A2

P50

Q35023076-20BBF4D9-DEC3-41CC-A151-549A7837411E

Q35023076-90C6D027-8C07-46CE-886D-6C4ABD585EE6

P577

Q35023076-2A6BE60C-CBDE-4EDD-8621-F043030D1AB0

P5875

Q35023076-442AD068-F84D-43E9-85B9-FF7C28AECE65

P698

Q35023076-914A7639-CF8B-4DA0-893F-71F8D1B25E51

P921

Q35023076-AB811166-DB1C-4C3F-A6F5-C17FD1292784

P932

Q35023076-4E57BC66-F29A-4B9F-A0C8-8AFE763AACDD

P356

JOURNAL.PONE.0117255

P1433

P1476

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice

@en

P2093

Eva Bengtsson

http://www.w3.org/2001/XMLSchema#string

Fong To

http://www.w3.org/2001/XMLSchema#string

Gunilla Nordin Fredrikson

http://www.w3.org/2001/XMLSchema#string

Ingrid Söderberg

http://www.w3.org/2001/XMLSchema#string

Irena Ljungcrantz

http://www.w3.org/2001/XMLSchema#string

Jan Nilsson

http://www.w3.org/2001/XMLSchema#string

Lena Sundius

http://www.w3.org/2001/XMLSchema#string

Polyxeni T Mantani

http://www.w3.org/2001/XMLSchema#string

Ragnar Alm

http://www.w3.org/2001/XMLSchema#string

P2860

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract

IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo

IL-33 reduces the development of atherosclerosis

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells

Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

The double life of a B-1 cell: self-reactivity selects for protective effector functions.

The immune system in atherosclerosis.

P304

e0117255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0117255

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Harry Björkbacka

P577

2015-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273954429

http://www.w3.org/2001/XMLSchema#string

P698

25629516

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4309452

http://www.w3.org/2001/XMLSchema#string